Alto Neuroscience logo

Alto Neuroscience

Healthcare & Life Sciences

Recent Finacing

Series C

Recent Raise

$45M


Alto Neuroscience specializes in precision psychiatry, developing targeted medicines based on its Precision Psychiatry Platform™, which utilizes brain biomarkers to match patients with appropriate treatments.

Total Funding

$45M

Headquarters

Los Altos, USA

Founded

N/A

Focus Areas

Precision Psychiatry
Brain Biomarkers
Drug Development
Clinical Trials
Depression Treatment
PTSD Treatment

Investors

Franklin Templeton logo
WhatIf Ventures logo
Lightswitch Capital logo
Windham Venture Partners logo
Alpha Wave Ventures logo
Eli Lilly and Company logo
Point72 logo
InVivium Capital logo
Alexandria Venture Investments logo